Alnylam Pharmaceuticals, Inc. (ALNY)
NASDAQ: ALNY · Real-Time Price · USD
432.52
+2.59 (0.60%)
At close: Aug 13, 2025, 4:00 PM
435.00
+2.48 (0.57%)
After-hours: Aug 13, 2025, 7:41 PM EDT

Alnylam Pharmaceuticals Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
1,114966.43812.69866.39819.98496.58
Upgrade
Short-Term Investments
1,7441,7281,6271,3261,6161,378
Upgrade
Cash & Short-Term Investments
2,8582,6952,4392,1922,4361,874
Upgrade
Cash Growth
8.88%10.46%11.27%-9.98%29.94%22.02%
Upgrade
Accounts Receivable
567.11405.31327.79237.96198.57102.41
Upgrade
Other Receivables
-----500
Upgrade
Receivables
567.11405.31327.79237.96198.57602.41
Upgrade
Inventory
71.6978.5189.15128.9686.3675.2
Upgrade
Prepaid Expenses
147.31116.96126.38132.9288.0862.77
Upgrade
Total Current Assets
3,6443,2952,9832,6922,8092,615
Upgrade
Property, Plant & Equipment
692.19693.93725.79738.63733.63706.51
Upgrade
Long-Term Deferred Tax Assets
104.36116.8610.1---
Upgrade
Other Long-Term Assets
125.77133.9111.29115.48101.185.77
Upgrade
Total Assets
4,5664,2403,8303,5463,6433,407
Upgrade
Accounts Payable
102.3988.4255.5298.0973.4351.97
Upgrade
Accrued Expenses
918.97795.16654.73513.78372.33299.27
Upgrade
Current Portion of Long-Term Debt
97.52113.0254.9940.2937.0813.32
Upgrade
Current Portion of Leases
46.141.8941.5141.9740.5536.87
Upgrade
Current Unearned Revenue
15.0855.48102.7542.11149.48127.21
Upgrade
Other Current Liabilities
120.7992.3158.2831.6822.8456.64
Upgrade
Total Current Liabilities
1,3011,186967.79767.92695.71585.27
Upgrade
Long-Term Debt
2,3722,3592,3432,2691,8271,250
Upgrade
Long-Term Leases
224.45229.54243.1261.34281.35293.04
Upgrade
Long-Term Unearned Revenue
--188.18193.79152.36225.09
Upgrade
Other Long-Term Liabilities
418.47398.11308.44212.5898.9632.71
Upgrade
Total Liabilities
4,3154,1734,0513,7053,0552,391
Upgrade
Common Stock
1.311.291.261.241.21.16
Upgrade
Additional Paid-In Capital
7,6917,3886,8116,4556,0585,644
Upgrade
Retained Earnings
-7,412-7,288-7,010-6,569-5,438-4,585
Upgrade
Comprehensive Income & Other
-29.95-34.52-23.38-44.65-33.26-43.62
Upgrade
Shareholders' Equity
250.5967.09-220.64-158.22588.21,016
Upgrade
Total Liabilities & Equity
4,5664,2403,8303,5463,6433,407
Upgrade
Total Debt
2,7402,7432,6832,6132,1861,593
Upgrade
Net Cash (Debt)
117.85-48.92-243.24-420.15249.87281.67
Upgrade
Net Cash Growth
-----11.29%-77.14%
Upgrade
Net Cash Per Share
0.91-0.38-1.95-3.452.112.45
Upgrade
Filing Date Shares Outstanding
131.08129.46125.95124.13120.21117
Upgrade
Total Common Shares Outstanding
130.98129.29125.79123.93120.18116.43
Upgrade
Working Capital
2,3432,1092,0151,9242,1132,030
Upgrade
Book Value Per Share
1.910.52-1.75-1.284.898.73
Upgrade
Tangible Book Value
250.5967.09-220.64-158.22588.21,016
Upgrade
Tangible Book Value Per Share
1.910.52-1.75-1.284.898.73
Upgrade
Land
-9.089.089.089.089.08
Upgrade
Buildings
-294.51271.65269.32262.64262.64
Upgrade
Machinery
-225.2202.89173.1137.86120.15
Upgrade
Construction In Progress
-7.6730.114.680.7528.01
Upgrade
Leasehold Improvements
-236.69235.41230.85152.05149.51
Upgrade
Updated Jul 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q